Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome : results from a cross-sectional analysis and a randomized , placebo-controlled , crossover trial 1 – 4


Background: Polycystic ovary syndrome (PCOS) is characterized by an adverse metabolic profile. Although dietary changes are advocated, optimal nutritional management remains uncertain. Polyunsaturated fatty acids (PUFAs), particularly long-chain (LC) n23 (omega-3) PUFAs, improve metabolic health, but their therapeutic potential in PCOS is unknown… (More)

10 Figures and Tables


  • Presentations referencing similar topics